Diabetes

Type 2 diabetes disease progression and successful intervention depend on individual’s unique clinical, genetic, genomic, and environmental information partly represented by gene expression patterns. An international team of researchers around…

Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases. In a Perspective in Cell Metabolism, Norbert Stefan from Helmholtz Munich, the German Center for Diabetes Research and the…

Matthias Hebrok about his new Institute for Diabetes and Organoid Technology (IDOT) at Helmholtz Munich

On Friday, February 3, 2023, the HI-MAG was able to present itself and its work at the SPIN2030 in the Congress Hall of the Leipzig Zoo with its own booth in cooperation with the University of Leipzig.

The pandemic, war, or climate change are stressful for many people. In response to stress, the body’s own hormones glucocorticoids are released. High stress hormone levels are associated with metabolic disease and aging, whereas dieting might…

Those affected are unsuspecting because a lipid metabolism disorder often causes no symptoms - until a heart attack or stroke occurs. However, patients are not powerless.

Diabetes

News

Diabetes type 2: New biomarkers for patient classification and intervention prediction identified

NAFLD - Hepatokines mediate its Impact on Metabolic Diseases and help to identify Subtypes

“Science must embrace invention, explore new avenues, test the unknown.”

HI-MAG presented itself at the SPIN2030

Mechanisms of stress hormones: ERC Consolidator Grant goes to Nina Henriette Uhlenhaut

Prof. Dr. Andreas Birkenfeld talks about the effects of a lipometabolic disorder.

Press Contact